These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8835836)

  • 1. Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria.
    Tod M; Rocchisani JM
    Comput Methods Programs Biomed; 1996 Jun; 50(1):13-22. PubMed ID: 8835836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.
    Tod M; Rocchisani JM
    J Pharmacokinet Biopharm; 1997 Aug; 25(4):515-37. PubMed ID: 9561492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of optimal sampling theory to the determination of metacycline pharmacokinetic parameters: effect of model misspecification.
    Tod M; Padoin C; Louchahi K; Moreau-Tod B; Petitjean O; Perret G
    J Pharmacokinet Biopharm; 1994 Apr; 22(2):129-46. PubMed ID: 7815309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.
    Tod M; Mentré F; Merlé Y; Mallet A
    J Pharmacokinet Biopharm; 1998 Dec; 26(6):689-716. PubMed ID: 10485081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust population pharmacokinetic experiment design.
    Dodds MG; Hooker AC; Vicini P
    J Pharmacokinet Pharmacodyn; 2005 Feb; 32(1):33-64. PubMed ID: 16205840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stochastic optimization algorithms of a Bayesian design criterion for Bayesian parameter estimation of nonlinear regression models: application in pharmacokinetics.
    Merlé Y; Mentré F
    Math Biosci; 1997 Aug; 144(1):45-70. PubMed ID: 9232968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal design for multivariate response pharmacokinetic models.
    Gueorguieva I; Aarons L; Ogungbenro K; Jorga KM; Rodgers T; Rowland M
    J Pharmacokinet Pharmacodyn; 2006 Apr; 33(2):97-124. PubMed ID: 16550455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trial.
    Chenel M; Ogungbenro K; Duval V; Laveille C; Jochemsen R; Aarons L
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):737-56. PubMed ID: 16341474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sampling schedule design towards optimal drug monitoring for individualizing therapy.
    Ji S; Zeng Y; Wu P; Lee EJ
    Comput Methods Programs Biomed; 2005 Oct; 80(1):57-63. PubMed ID: 16040154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments.
    Ogungbenro K; Graham G; Gueorguieva I; Aarons L
    Comput Methods Programs Biomed; 2005 Nov; 80(2):115-25. PubMed ID: 16139390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of using a robust optimality criterion in model based adaptive optimization.
    Strömberg EA; Hooker AC
    J Pharmacokinet Pharmacodyn; 2017 Aug; 44(4):317-324. PubMed ID: 28386710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule.
    Schoemaker NE; Mathôt RA; Schöffski P; Rosing H; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):514-7. PubMed ID: 12451480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertainty.
    Dokoumetzidis A; Aarons L
    J Biopharm Stat; 2007; 17(5):851-67. PubMed ID: 17885870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients.
    de Castro FA; Piana C; Simões BP; Lanchote VL; Della Pasqua O
    Br J Clin Pharmacol; 2015 Oct; 80(4):618-29. PubMed ID: 25819742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
    Bos AM; Boom K; Vinks AA; Boezen HM; Wanders J; Dombernovsky P; Aamdal S; de Vries EG; Uges DR
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):64-70. PubMed ID: 15069581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring.
    Merlé Y; Mentré F
    J Pharmacokinet Biopharm; 1999 Feb; 27(1):85-101. PubMed ID: 10533699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PERMMA: Enhancing parameter estimation of software reliability growth models: A comparative analysis of metaheuristic optimization algorithms.
    Pradhan V; Patra A; Jain A; Jain G; Kumar A; Dhar J; Bandyopadhyay A; Mallik S; Ahmad N; Badawy AS
    PLoS One; 2024; 19(9):e0304055. PubMed ID: 39231125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.
    Leroux S; Turner MA; Guellec CB; Hill H; van den Anker JN; Kearns GL; Jacqz-Aigrain E; Zhao W;
    Clin Pharmacokinet; 2015 Dec; 54(12):1273-85. PubMed ID: 26063050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.